Search

everythinglearnresearchcommunity

for

Search:↓

Hair restoration has evolved from surgery to drugs to potential gene therapy, with improved results and ongoing research driven by high demand.

EF and PXE not closely related.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

Various treatments exist for hair loss, but more research is needed for better options.

Resveratrol helps prevent finasteride-induced damage in male rats, improving reproductive function.

Minoxidil and Finasteride are the most popular hair loss treatments, with rising interest in other options, and economic or health crises can change what treatments people prefer.

LLLT is a safe, promising hair loss treatment, but more research needed.

Astragalus membranaceus helps regrow hair and reduce hair loss symptoms.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

A new topical treatment using SAMiRNA technology shows promise in increasing hair growth for androgenetic alopecia.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Herbs might help with hair loss, but more research is needed to confirm their safety and effectiveness.